生物等效性
去氨加压素
交叉研究
医学
曲线下面积
药代动力学
方差分析
药理学
内科学
安慰剂
病理
替代医学
作者
Stefan T. Kaehler,Ilka Steiner,Robert Sauermann,Helmut Scheidl,Markus Mueller,Christian Joukhadar
出处
期刊:Pharmacology
[S. Karger AG]
日期:2006-01-01
卷期号:77 (1): 46-52
被引量:6
摘要
The present study was carried out to test bioequivalence between two different oral desmopressin formulations. Sixty healthy volunteers were enrolled in the study and were randomly assigned to receive the test (T) and reference (R) drug in a two-period two-sequence, crossover, analyst-blinded study design. Subjects received an oral dose of 400 µg of desmopressin acetate separated by a wash-out period of at least 7 days. The area under the concentration-time curve (AUC) over 12 h in plasma and the maximum concentration (C<sub>max</sub>) were compared by analysis of variance (ANOVA) after log transformation. The mean ratios of the T to R drug were within the bioequivalence boundaries with mean values of 1.00 (90% CI: 0.87–1.14) and 1.03 (90% CI: 0.92–1.15) for AUC<sub>0–t</sub> and AUC<sub>0–inf</sub>, respectively. For the C<sub>max</sub>, the mean ratio of the T to R drug was 0.97 (90% CI: 0.87–1.08). The rate and the extent of oral desmopressin absorption were identical for both formulations. Hence, the desmopressin test tablet met all bioequivalence criteria of the marketed reference desmopressin tablet.
科研通智能强力驱动
Strongly Powered by AbleSci AI